Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sepideh Mirzaei

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Expert Reviews in Molecular Medicine|September 29, 2021
MicroRNAs regulating SOX2 in cancer progression and therapy responseSepideh Mirzaei, Hamidreza Saebfar, Mohammad Hossein Gholami, et al.
Life Sciences|May 27, 2021
Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospectsMilad Ashrafizadeh, Sepideh Mirzaei, Kiavash Hushmandi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2022
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigationMaliheh Entezari, Danial Hashemi, Afshin Taheriazam, et al.
Cells|December 24, 2021
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer TherapySepideh Mirzaei, Mohammad Hossein Gholami, Hui Li Ang, et al.
European Journal of Pharmacology|July 16, 2021
The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targetsSepideh Mirzaei, Asal Jalal Abadi, Mohammad Hossein Gholami, et al.
Annals of Coloproctology|November 15, 2019
Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical TrialHamid Nasrolahi, Sepideh Mirzaei, Mohammad Mohammadianpanah, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 7, 2026
Retraction notice to "AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation" [Biomedicine & Pharmacotherapy 146 (2022) 112563]Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic StrategiesSepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, et al.
Life Sciences|January 9, 2021
Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasisMilad Ashrafizadeh, Mohammad Hossein Gholami, Sepideh Mirzaei, et al.
Journal of Hematology & Oncology|March 3, 2022
The long and short non-coding RNAs modulating EZH2 signaling in cancerSepideh Mirzaei, Mohammad Hossein Gholami, Kiavash Hushmandi, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Expert Reviews in Molecular Medicine|September 29, 2021
MicroRNAs regulating SOX2 in cancer progression and therapy responseSepideh Mirzaei, Hamidreza Saebfar, Mohammad Hossein Gholami, et al.
Life Sciences|May 27, 2021
Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospectsMilad Ashrafizadeh, Sepideh Mirzaei, Kiavash Hushmandi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2022
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigationMaliheh Entezari, Danial Hashemi, Afshin Taheriazam, et al.
Cells|December 24, 2021
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer TherapySepideh Mirzaei, Mohammad Hossein Gholami, Hui Li Ang, et al.
European Journal of Pharmacology|July 16, 2021
The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targetsSepideh Mirzaei, Asal Jalal Abadi, Mohammad Hossein Gholami, et al.
Annals of Coloproctology|November 15, 2019
Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical TrialHamid Nasrolahi, Sepideh Mirzaei, Mohammad Mohammadianpanah, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 7, 2026
Retraction notice to "AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation" [Biomedicine & Pharmacotherapy 146 (2022) 112563]Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic StrategiesSepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, et al.
Life Sciences|January 9, 2021
Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasisMilad Ashrafizadeh, Mohammad Hossein Gholami, Sepideh Mirzaei, et al.
Journal of Hematology & Oncology|March 3, 2022
The long and short non-coding RNAs modulating EZH2 signaling in cancerSepideh Mirzaei, Mohammad Hossein Gholami, Kiavash Hushmandi, et al.
Pageof 10